Protein kinase C as a therapeutic target.
Teicher
Beverly A
BA
Genzyme Corporation, Framingham, Massachusetts 01701-9322, USA. Beverly.Teicher@Genzyme.com
D000818:Animals; D001932:Brain Neoplasms / Q000209:etiology / Q000235:genetics / Q000378:metabolism; D016503:Drug Delivery Systems / Q000379:methods; D005260:Female; D006801:Humans; D008297:Male; D008954:Models, Biological; D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism; D011493:Protein Kinase C / Q000502:physiology*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use
D047428:Protein Kinase Inhibitors; D011493:Protein Kinase C